Tag: china

Bio-Printing Organs: China Moving in the Right Direction

Chinese scientists have announced a step forward in the field of regenerative medicine for their nation. Researchers from eastern china have revealed a 3D Bio-Printer which uses a biological gel as its building material, to create and form rudimentary organs and body parts, Reuters reports. With scandal surrounding Chinese institutions in charge of organ donation, […]

Continue Reading

Discounts needed to access China pharma market

Discounts needed to access China pharma market

"If we can arrange an appropriate, acceptable, affordable price, then you can have a huge market," says China's top health official, Chen Zhu, who stepped down last month (Bloomberg). Health-care spending in China – now the world' third-largest pharmaceutical market – is expected to almost triple by 2020 to $1 trillion a year. However, if […]

Continue Reading

Sanofi plans China growth with 4 new plants

Sanofi plans China growth with 4 new plants

Sanofi plans to open four manufacturing plants this year in China, reports the Wall Street Journal. The WSJ reports that Sanofi expects to see "double-digit sales growth" in the next five years in China, and plans to expand its animal health and vaccine business in the country. The French pharmaceutical company currently has six plants […]

Continue Reading

Is China prepared for orphan drug development and access?

Is China prepared for orphan drug development and access?

As the orphan drug market grows exponentially, everyone is looking into China and whether the country is prepared to provide access for therapies to rare disease patients. Pharma companies like Genzyme have made strong efforts to introduce one of its orphan drugs in China and into the healthcare system in force. China has reached a […]

Continue Reading

Guest Blog–A global fight against rare diseases/disorders

Guest Blog–A global fight against rare diseases/disorders

Written by on July 5, 2012 in Orphan Drugs with 0 Comments

    Rare diseases matter. Remco de Vrueh, Founder of the virtual research platform Rare Disease Matters has kindly allowed me to post his most recent blog that highlights the global distribution of rare diseases and that the orphan drug development "buck" does not stop with the US, Europe and Japan. It is my pleasure […]

Continue Reading

BioPharma Opening Plenary

BioPharma Opening Plenary

Written by on March 21, 2012 in Manufacturing with 0 Comments

The 2012 edition of the BioPharma Asia Convention opened with a plenary session with the 4 leaders of from the pharmaceutical world. They discussed the future of their industry in the asian region. Members of the panel include, Salomon Azoulay from Pfizer USA, Andreas Busch from Bayer Health Care, Anand Tharmaratnam from Quintiles and Chihiro […]

Continue Reading

Pfizer: Forging Strategic Alliances With Partners in India and China

Pfizer: Forging Strategic Alliances With Partners in India and China

Written by on March 21, 2012 in Clinical Trials, Manufacturing with 0 Comments

One of the most important themes that emerge is that pharmaceutical firms need to look at forging serious partnerships in the economic powerhouses that is India and China. It goes without saying that their rapid growth thus and huge potential for further growth means that any company worth it’s weigh in salt has to have […]

Continue Reading

Whitepaper Download – Managing Clinical Trials and Central Laboratory Services in China, by PPD

Whitepaper Download – Managing Clinical Trials and Central Laboratory Services in China, by PPD

Written by on February 17, 2012 in Clinical Trials, Reports with 0 Comments

China's huge population and growing commitment to health care are predicted to make the country the world's second-largest consumer of pharmaceuticals by 2015. However, despite the size of the market, the large numbers of treatment-naïve patients, and the necessity of collecting clinical trial data patients in China before the Chinese State Food and Drug Administration […]

Continue Reading

Quintiles launches China CRO, Kun Tuo

Quintiles launches China CRO, Kun Tuo

Written by on February 16, 2012 in Clinical Trials, Manufacturing, Partnering & Investment with 0 Comments

Contributed by Quintiles: FURTHER deepening its commitment to China, Quintiles today announced the launch of Kun Tuo (koon-TOO-ah), a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China. Building on Quintiles' unmatched success at the global level, and experience in conducting […]

Continue Reading

Quintiles launches innovative center of excellence in Dalian, China

Quintiles launches innovative center of excellence in Dalian, China

Written by on February 13, 2012 in Partnering & Investment with 1 Comment

Contributed by Quintiles: Quintiles today announced the opening of a business process outsourcing (BPO) and project management center of excellence in Dalian, a major city in northeast China with a multilingual workforce and location ideally suited to serve the Japanese, Chinese and South Korean biopharmaceutical markets. The Dalian office will provide data management, biostatistics, medical […]

Continue Reading

Article Download – Forging New Relationships in China’s Consolidating Distribution Industry

Article Download – Forging New Relationships in China’s Consolidating Distribution Industry

Written by on February 10, 2012 in Reports with 0 Comments

Slightly more than a year ago, in August 2010, China's Ministry of Commerce unveiled a draft plan designed to help effect a major restructuring of the country's drug distribution system. The goal, according to the plan's authors, was to reduce what until recently had been some 16,500 pharmaceutical wholesalers and 140,000 retailers to no more […]

Continue Reading

Top
Geolocation